Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery

Artificial Organs

Volumn 20, Issue 9, 1996, Pages 1008-1016

  Bozdayi, Mithat ^a   Borowiec, Jan ^a   Nilsson, Leif ^a   Venge, Per ^a   Thelin, Stefan ^a   Hansson, Hans Erik ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiopulmonary bypass; Granulocyte derived enzymes; Heparin coating; Oxygen free radicals

Indexed keywords

BLOOD; COATINGS; FREE RADICALS; OXYGEN; POLYSACCHARIDES; TIMING CIRCUITS;

C-MEANS; CARDIOPULMONARY BYPASS; CARDIOPULMONARY BYPASS CIRCUIT; GRANULOCYTE-DERIVED ENZYME; HEPARIN COATINGS; IN-VITRO; LACTOFERRIN; MYELOPEROXIDASE; OXYGEN FREE RADICALS; WHOLE BLOOD;

CHEMICAL ACTIVATION;

FREE RADICAL; HEPARIN; OXYGEN RADICAL;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029759210     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1996.tb04588.x     Document Type: Article

References (25)

1. Nilsson L, Bagge L, Nyström SO. Blood cell trauma and postoperative bleeding: Comparison of bubble and membrane oxygenators and observations on coronary suction. Scand J Thorac Cardiovasc Surg 1990;24:65-9.
2. Hashimoto K, Miyamoto H, Suzuki K, Horikoshi S, Matsui M, Arai T, Kurosawa H. Evidence of organ damage after cardiopulmonary bypass. The role of elastase and vasoactive mediators. J Thorac Cardiovasc Surg 1992;104:666-73.
3. Jansen NJG, van Oeveren W, van Vliet M, Stoutenbeek CP, Eysman L, Wildevuur CRH. The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. Eur J Cardiothorac Surg 1991;5:211-7.
4. Borowiec J, Thelin S, Bagge L, Nilsson L, Venge P, Hansson H-K. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass: A clinical study. J Thorac Cardiovasc Surg 1992;104:642-7.
5. Antonsen S, Brandslund I, Clemesen S, Soefeldt S, Madsen T, Alstrup P. Neutrophil lysosomal enzyme release and complement activation during cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg 1987;21:47-52.
6. Downing SW, Edmunds LH Jr. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 1992;54:1236-43.
7. Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, McCord JM, Harman D. Oxygen free radicals and human disease. Ann Int Med 1987;107:526-45.
8. Elstner EF. Oxygen radicals: Biochemical basis for their efficacy. Klin Wochenschr 1991;69:949-56.
9. Yau TM, Mickle DAG, Weisel RD. Myocardial free radical reperfusion injury during cardiac surgery. Cardiac Surgery: State of the art reviews 1990;4:703-12.
10. Prasad K, Katra J, Bharadwaj B, Chaudhary AK. Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery. Am Heart J 1992;123:37-45.
11. Videm V, Svennevig J, Fosse E, Semb G, Osterud A, Mollnes TE. Reduced complement activation with heparin coated oxygenator and tubings in coronary bypass surgery. J Thorac Cardiovasc Surg 1992;103:806-13.
12. Larm O, Larsson R, Olsson P. A new non-thrombogenic surface prepared by selective covalent binding to heparin via a modified reducing terminal residue. Biomater Med Devices Artif Organs 1983;2:161-3.
13. Arnander C, Dryjski M, Larsson R, Olsson P, Swedenborg J. Trombin uptake and inhibition on endothelium and surface with a stable heparin coating. A comparative in vitro study. J Biomed Mater Res 1986;20:235-46.
14. Allen RC, Stjernholm RL, Steele RH. Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun 1972;47: 679-84.
15. Tono-oka T, Ueno N, Matsumato T, Okhawa M, Matsumato S. Chemiluminescence of whole blood. A simple and rapid method for estimation of phagocytic function of granulocytes and opsonic activity in whole blood. Clin Immnnol Immunopathol 1983;26:66-75.
16. Boeckx RL. Chemiluminescence. Applications for the clinical laboratory. Hum Pathol 1984;15:104-11.
17. Semb AG, Vaage J, Lie M, Sorlie D, Mjös OD. Leucocytes and cardiopulmonary bypass. In vitro production of oxygen free radicals and trapping in the reperfused myocardium. Perfusion 1990;5:169-80.
18. Roccatello D, Formica M, Cavalli G, Amprimo MC, Pignatelli MG, Costa P, de Paulis R, Quattrorocchio G, Molino A, Giordano G. Changes in neutrophil oxidative potential in patients undergoing cardiopulmonary bypass with polypropylene hollow fiber oxygenators. Artif Organs 1990;14: 69-72.
19. Davies SW, Underwood SM, Wickens DG, Feneck KO, Dormandy TL, Walesby RK. Systemic pattern of free radical generation during bypass surgery. Br Heart J 1990;64: 236-40.
20. Cavarocchi NC, England MD, Schaff HV, Russo P, Orszulak TA, Schnell WA Jr, O'Brien JF, Pluth JR, Oxygen free radical generation during cardiopulmonary bypass: Correlation with complement activation. Circulation 1986 (Suppl 3):74:130-3.
21. Davies SW, Duffy JP, Wickens DG, Underwood SM, Hill A, Alladine MF, Feneck RO, Dormand TL, Walesby RK. Time course of free radical activity during coronary artery operations with cardiopulmonury bypass. J Thorac Cardiovasc Surg 1993;105:979-87.
22. Trulson A, Nilsson S, Venge P. Lucigenin-enhanced chemiluminescence in blood is increased in cancer. Am J Clin Pathol 1989;91:441-5.
23. Borowiec JW, Hagman L, Tötterman TH, Pekna M, Thelin S. Circulating cytokines and granulocyte derived enzymes during complex heart surgery: A clinical study, with special reference to heparin-coating of cardiopulmonary bypass circuits. Scand J Thorac Cardiovasc Surg 1996: (in press).
24. Courtney JM, Irvine L, Gaylor JDS, Forbes CD, Taylor KM. Influence of cardiopulmonary bypass on blood components. In: Hastings GW, ed. Cardiovascular biomaterials. London: Springer, 1992:37-79.
25. Aniansson H, Stendhal O, Dahlgren C. Comparison between luminol- and lucigenindependent chemiluminescence of polymorphonuclear leukocytes. Acta Path Microbiol Immunol Scand 1984;92:357-61.